Rafferty Asset Management, LLC

Position in PGEN — Precigen, Inc.

CIK 1389426 New York, NY

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,122,626

-$112,724 QoQ

Shares Held

196,952

-38.3% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#61

of 210 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. PGEN ranks #83 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	65,798	$32,683,840
2	REGN	Regeneron Pharmaceuticals, Inc.	38,534	$24,027,490
3	ALNY	Alnylam Pharmaceuticals, Inc.	55,332	$16,656,591
4	MRNA	Moderna, Inc.	111,906	$7,836,777
5	INCY	Incyte Corp	44,663	$5,062,997
6	APGE	Apogee Therapeutics, Inc.	33,369	$4,429,067
7	TWST	Twist Bioscience Corp	40,732	$4,190,508
8	ORKA	Oruka Therapeutics, Inc.	43,110	$4,102,778

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,122,626	196,952	-38.3%	Shares	Sole	2026-08-14
2026-03-31	$1,235,350	319,212	-14.7%	Shares	Sole	2026-05-15
2025-12-31	$1,564,164	374,202	+264.3%	Shares	Sole	2026-02-13
2025-09-30	$337,961	102,724	-78.3%	Shares	Sole	2025-11-12
2021-12-31	$1,758,877	474,091	+170.3%	Shares	Sole	2022-02-10
2021-09-30	$875,111	175,373	-24.3%	Shares	Sole	2021-11-10
2021-06-30	$1,511,427	231,814	-37.7%	Shares	Sole	2021-08-10
2021-03-31	$2,562,074	371,854	+1403.6%	Shares	Sole	2021-05-10
2020-12-31	$252,256	24,731	-74.6%	Shares	Sole	2021-02-10
2020-09-30	$340,504	97,287	+618.5%	Shares	Sole	2020-11-13
2020-03-31	$46,039	13,541	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.